RAPT Therapeutics Inc (NASDAQ: RAPT) is -95.69% lower on its value in year-to-date trading and has touched a low of $1.01 and a high of $27.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RAPT stock was last observed hovering at around $1.07 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $1.07, the stock is -44.06% and -43.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 0.00% at the moment leaves the stock -79.50% off its SMA200. RAPT registered -92.32% loss for a year compared to 6-month loss of -76.89%. The firm has a 50-day simple moving average (SMA 50) of $1.8954 and a 200-day simple moving average (SMA200) of $5.34375.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -40.22% gain in the last 1 month and extending the period to 3 months gives it a -53.48%, and is -31.85% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.06% over the week and 17.77% over the month.
RAPT Therapeutics Inc (RAPT) has around 131 employees, a market worth around $37.41M and $0.00M in sales. Distance from 52-week low is 5.94% and -96.09% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.57%).
The EPS is expected to grow by 20.27% this year
144.0 institutions hold shares in RAPT Therapeutics Inc (RAPT), with institutional investors hold 88.27% of the company’s shares. The shares outstanding are 34.40M, and float is at 30.55M with Short Float at 8.73%. Institutions hold 86.65% of the Float.
The top institutional shareholder in the company is FMR LLC with over 5.24 million shares valued at $15.97 million. The investor’s holdings represent 13.5546 of the RAPT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.11 million shares valued at $9.48 million to account for 8.0472 of the shares outstanding. The other top investors are COLUMN GROUP LLC which holds 2.68 million shares representing 6.9401 and valued at over $8.18 million, while BLACKROCK INC. holds 6.3167 of the shares totaling 2.44 million with a market value of $7.44 million.
RAPT Therapeutics Inc (RAPT) Insider Activity
The most recent transaction is an insider sale by Brockstedt Dirk G., the company’s CHIEF SCIENTIFIC OFFICER. SEC filings show that Brockstedt Dirk G. sold 898 shares of the company’s common stock on Jan 05 ’24 at a price of $22.78 per share for a total of $20456.0. Following the sale, the insider now owns 27820.0 shares.
RAPT Therapeutics Inc disclosed in a document filed with the SEC on Dec 21 ’23 that HO WILLIAM (Chief Medical Officer) sold a total of 2,500 shares of the company’s common stock. The trade occurred on Dec 21 ’23 and was made at $21.68 per share for $54200.0. Following the transaction, the insider now directly holds 15020.0 shares of the RAPT stock.
Still, SEC filings show that on Nov 28 ’23, HO WILLIAM (Chief Medical Officer) disposed off 1,500 shares at an average price of $13.72 for $20580.0. The insider now directly holds 17,520 shares of RAPT Therapeutics Inc (RAPT).
